Complete Filing Data
FGI Industries Ltd. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $22.74 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean FGI Industries Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Income * | -$1.2M | $733.6K | $3.7M | $7.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.1M | $284.8K | -$741.6K | $59.1K |
| Selling And Marketing Expense | $25.6M | $20.0M | $17.5M | $17.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $131.8M | $117.2M | $161.7M | $181.9M |
| Research And Development Expense | $1.7M | $1.4M | $1.1M | $646.1K |
| Other Nonoperating Income Expense | $1.1M | -$177.5K | $46.2K | $1.5M |
| Operating Income Loss | -$2.1M | $2.3M | $5.1M | $7.7M |
| Operating Expenses | $37.5M | $29.8M | $26.4M | $24.5M |
| Nonoperating Income Expense | -$182.5K | -$916.7K | -$551.4K | $1.1M |
| Income Tax Expense Benefit | -$547.8K | $808.2K | $860.6K | $961.6K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.3M | $1.4M | $4.5M | $8.9M |
| Gross Profit | $35.4M | $32.1M | $31.5M | $32.2M |
| General And Administrative Expense | $10.2M | $8.4M | $7.8M | $6.2M |
| Deferred Income Tax Expense Benefit | -$1.5M | $96.7K | $201.9K | -$221.6K |
| Current Income Tax Expense Benefit | $963.5K | $711.5K | $658.7K | $1.2M |
| Cost Of Revenue | $96.4M | $85.2M | $130.2M | $149.7M |
| Comprehensive Income Net Of Tax | -$2.3M | $1.0M | $2.9M | $8.0M |
| Income Taxes Paid Net | $1.1M | $552.2K | $1.8M | $545.1K |
| Deferred Income Taxes And Tax Credits | -$1.5M | $96.7K | $213.1K | -$215.2K |
| Deferred Income Tax Assets Net | $1.2M | $1.3M | $1.5M | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.9M | $864.4K | $2.9M | |
| Accrued Income Taxes Current | $189.1K | $33.4K | $1.2M | |
| Interest Expense | $749.7K | $600.8K | $411.2K | |
| Net Income Loss Attributable To Noncontrolling Interest | -$533.2K | -$154.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.7M | -$1.2M | -$629.1K | -$550.1K | $163.6K | -$412.2K | $409.5K | $88.5K | -$303.4K | $1.3M | $1.2M | $530.2K | $1.4M | $2.5M | $3.0M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$3.7K | $603.0K | $86.4K | $47.3K | -$425.0K | -$22.6K | -$44.5K | $4.9K | $20.1K | -$879.7K | -$69.4K | -$57.2K | -$354.9K | $325.6K | -$401.00 | |
| Selling And Marketing Expense | $6.1M | $6.2M | $7.2M | $6.3M | $6.3M | $6.1M | $4.6M | $4.8M | $4.7M | $4.3M | $4.4M | $4.7M | $4.6M | $4.1M | $3.9M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $35.8M | $31.0M | $33.2M | $36.1M | $29.4M | $30.8M | $29.9M | $29.2M | $27.2M | $38.5M | $47.8M | $43.6M | $50.9M | $42.5M | $36.4M | |
| Research And Development Expense | $283.9K | $484.5K | $316.7K | $452.0K | $530.8K | $320.7K | $423.7K | $377.1K | $351.8K | $238.6K | $235.7K | $313.7K | $197.0K | $155.4K | $133.8K | |
| Other Nonoperating Income Expense | -$36.0K | -$466.2K | $28.1K | $951.00 | $429.5K | $27.0K | $49.6K | -$10.7K | -$19.6K | $71.8K | -$66.1K | $98.8K | -$59.4K | -$101.3K | $1.6M | |
| Operating Income Loss | $369.7K | -$832.3K | -$1.3M | -$65.8K | -$450.4K | -$320.9K | $481.7K | $580.3K | -$2.9K | $1.7M | $1.7M | $690.7K | $1.8M | $3.3M | $1.9M | |
| Operating Expenses | $9.1M | $9.5M | $10.2M | $9.4M | $9.4M | $8.7M | $7.3M | $7.4M | $7.2M | $6.4M | $6.7M | $6.8M | $6.3M | $5.9M | $5.4M | |
| Nonoperating Income Expense | -$438.2K | -$746.7K | -$274.2K | -$364.9K | $128.5K | -$194.6K | $34.3K | -$300.3K | -$267.8K | -$87.0K | -$173.4K | -$32.9K | -$180.0K | -$184.7K | $1.5M | |
| Income Tax Expense Benefit | $1.9M | -$214.6K | -$739.5K | $267.5K | -$298.4K | $22.3K | $172.5K | $191.4K | $32.6K | $309.2K | $385.4K | $127.7K | $231.7K | $628.3K | $455.5K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$68.5K | -$1.6M | -$1.6M | -$430.7K | -$321.8K | -$515.6K | $516.0K | $279.9K | -$270.7K | $1.6M | $1.6M | $657.9K | $1.6M | $3.1M | $3.4M | |
| Gross Profit | $9.5M | $8.7M | $8.9M | $9.3M | $9.0M | $8.4M | $7.8M | $8.0M | $7.2M | $8.0M | $8.4M | $7.5M | $8.1M | $9.2M | $7.3M | |
| General And Administrative Expense | $2.8M | $2.8M | $2.7M | $2.6M | $2.6M | $2.3M | $2.4M | $2.3M | $2.1M | $1.9M | $2.1M | $1.8M | $1.5M | $1.6M | $1.4M | |
| Deferred Income Tax Expense Benefit | $1.6M | -$243.9K | -$758.7K | -$251.0K | -$566.3K | -$48.5K | -$52.6K | $9.7K | -$100.2K | $54.3K | $87.1K | -$43.8K | -$24.3K | $99.8K | $150.5K | |
| Current Income Tax Expense Benefit | $236.2K | $29.3K | $19.2K | $518.6K | $267.9K | $70.8K | $225.1K | $181.8K | $132.8K | $254.9K | $298.3K | $171.5K | $256.1K | $528.6K | $305.0K | |
| Cost Of Revenue | $26.4M | $22.3M | $24.3M | $26.8M | $20.4M | $22.3M | $22.1M | $21.2M | $20.0M | $30.5M | $39.4M | $36.1M | $42.8M | $33.3M | $29.1M | |
| Comprehensive Income Net Of Tax | -$1.7M | -$628.5K | -$542.7K | -$502.9K | -$261.4K | -$434.8K | $365.0K | $93.4K | -$283.3K | $392.4K | $1.1M | $473.0K | $1.0M | $2.8M | $3.0M | |
| Income Taxes Paid Net | $850.00 | $486.5K | $2.3K | $784.7K | $15.8K | |||||||||||
| Deferred Income Taxes And Tax Credits | -$758.7K | -$48.5K | -$100.2K | -$32.7K | $140.9K | |||||||||||
| Deferred Income Tax Assets Net | $2.0M | $3.7M | $3.4M | $2.7M | $2.0M | $1.8M | $1.2M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.5M | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.0M | -$761.4K | -$729.1K | -$651.0K | -$448.4K | -$560.4K | $299.0K | $93.4K | -$283.3K | $392.4K | ||||||
| Accrued Income Taxes Current | $0.00 | $51.4K | $41.0K | $23.2K | $64.8K | $222.3K | $142.5K | $163.8K | $172.8K | $875.8K | $604.0K | |||||
| Interest Expense | $222.2K | $16.4K | $293.7K | $249.6K | $159.0K | $107.4K | $131.8K | $120.6K | $86.0K | $81.3K | ||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$296.7K | -$132.9K | -$186.5K | -$148.1K | -$187.0K | -$125.7K | -$66.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Stockholders Equity * | $24.2M | $22.7M | $7.5M | $1.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.1M | $3.9M | $4.0M | ||
| Provision For Accrued Defective Return And Discount On Accounts Receivable Current | -$851.6K | -$1.7M | $2.1M | ||
| Property Plant And Equipment Net | $1.9M | $1.3M | $387.7K | ||
| Other Assets Noncurrent | $1.2M | $2.1M | $3.0M | ||
| Operating Lease Right Of Use Asset | $15.2M | $9.8M | $8.1M | ||
| Operating Lease Liability Noncurrent | $13.7M | $7.8M | $6.9M | ||
| Operating Lease Liability Current | $1.6M | $1.5M | $1.3M | ||
| Liabilities Current | $28.0M | $29.8M | $54.7M | ||
| Liabilities And Stockholders Equity | $65.7M | $60.4M | $69.2M | ||
| Liabilities | $41.7M | $37.6M | $61.6M | ||
| Inventory Net | $9.9M | $13.3M | $21.3M | ||
| Common Stock Value | $955.00 | $950.00 | $700.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.2M | -$2.3M | $6.2M | -$134.7K | |
| Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment | $17.7M | $13.2M | $12.6M | ||
| Assets Current | $46.1M | $45.9M | $56.2M | ||
| Assets | $65.7M | $60.4M | $69.2M | ||
| Accrued Expenses And Other Current Liabilities | $4.0M | $3.6M | $5.5M | ||
| Accounts Receivable Net Current | $16.2M | $14.3M | $26.4M | ||
| Retained Earnings Accumulated Deficit | $4.4M | $3.7M | |||
| Additional Paid In Capital Common Stock | $20.9M | $20.5M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.1M | -$1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $19.7M | $21.3M | $21.8M | $22.3M | $23.5M | $23.8M | $23.9M | $24.0M | $23.3M | $22.8M | $22.6M | $22.1M | $21.6M | $20.4M | $2.8M | -$104.3K | $3.2M | $1.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.9M | $2.5M | $1.2M | $4.6M | $3.0M | $1.3M | $3.3M | $7.8M | $5.4M | $6.9M | $7.4M | $6.0M | $3.1M | $8.8M | $3.2M | $3.8M | $1.8M | |
| Provision For Accrued Defective Return And Discount On Accounts Receivable Current | $257.6K | $671.2K | $460.3K | -$284.5K | $653.0K | |||||||||||||
| Property Plant And Equipment Net | $4.0M | $3.9M | $3.8M | $3.6M | $3.0M | $2.9M | $2.4M | $1.4M | $1.4M | $1.3M | $1.6M | $333.5K | $362.1K | |||||
| Other Assets Noncurrent | $1.1M | $1.3M | $1.4M | $1.6M | $1.9M | $1.7M | $1.6M | $1.6M | $1.9M | $2.2M | $2.3M | $3.1M | $3.6M | |||||
| Operating Lease Right Of Use Asset | $11.4M | $11.9M | $11.4M | $12.8M | $13.5M | $14.0M | $14.7M | $15.5M | $16.0M | $16.3M | $9.6M | $7.5M | $7.8M | |||||
| Operating Lease Liability Noncurrent | $10.4M | $10.8M | $10.3M | $11.4M | $12.1M | $12.5M | $13.2M | $13.9M | $14.3M | $14.6M | $8.5M | $6.4M | $6.6M | |||||
| Operating Lease Liability Current | $1.7M | $1.6M | $1.5M | $1.9M | $1.8M | $1.7M | $1.7M | $1.5M | $1.3M | $1.2M | $1.2M | $1.2M | $1.3M | |||||
| Liabilities Current | $44.2M | $40.6M | $37.2M | $42.5M | $39.7M | $34.0M | $31.8M | $29.8M | $27.3M | $21.5M | $32.8M | $42.4M | $46.8M | |||||
| Liabilities And Stockholders Equity | $73.0M | $71.7M | $68.5M | $75.5M | $74.7M | $69.9M | $68.6M | $66.9M | $64.5M | $58.7M | $63.4M | $70.5M | $73.9M | |||||
| Liabilities | $54.6M | $51.4M | $47.5M | $53.9M | $51.8M | $46.5M | $45.0M | $43.8M | $41.6M | $36.1M | $41.3M | $48.8M | $53.4M | |||||
| Inventory Net | $12.3M | $12.7M | $12.6M | $14.0M | $13.8M | $12.8M | $11.6M | $9.6M | $9.8M | $9.9M | $16.0M | $18.7M | $21.6M | |||||
| Common Stock Value | $959.00 | $959.00 | $959.00 | $956.00 | $956.00 | $956.00 | $955.00 | $950.00 | $950.00 | $950.00 | $950.00 | $950.00 | $950.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.3M | -$4.5M | -$2.7M | $4.9M | -$2.2M | |||||||||||||
| Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment | $16.4M | $18.7M | $18.1M | $18.9M | $19.3M | $19.5M | $17.6M | $18.5M | $19.2M | $19.8M | $13.3M | $12.0M | $12.9M | |||||
| Assets Current | $52.7M | $49.1M | $46.5M | $52.9M | $52.4M | $47.5M | $48.6M | $47.1M | $43.8M | $37.6M | $48.5M | $58.1M | $60.6M | |||||
| Assets | $73.0M | $71.7M | $68.5M | $75.5M | $74.7M | $69.9M | $68.6M | $66.9M | $64.5M | $58.7M | $63.4M | $70.5M | $73.9M | |||||
| Accrued Expenses And Other Current Liabilities | $5.8M | $4.7M | $5.3M | $5.9M | $5.1M | $4.3M | $3.4M | $3.7M | $3.8M | $3.0M | $4.0M | $4.5M | $4.7M | |||||
| Accounts Receivable Net Current | $18.1M | $15.7M | $18.9M | $20.3M | $19.0M | $17.6M | $15.7M | $16.6M | $14.3M | $12.1M | $18.2M | $25.1M | $20.6M | |||||
| Retained Earnings Accumulated Deficit | -$299.5K | $1.4M | $2.6M | $3.2M | $3.6M | $4.2M | $4.0M | $3.9M | $3.5M | $3.4M | $3.0M | $1.7M | $530.2K | |||||
| Additional Paid In Capital Common Stock | $21.6M | $21.5M | $21.4M | $21.3M | $21.4M | $21.2M | $21.0M | $20.8M | $20.7M | $20.6M | $20.8M | $20.7M | $20.6M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.6M | -$1.6M | -$2.2M | -$2.2M | -$1.5M | -$1.6M | -$1.1M | -$1.4M | -$1.4M | -$1.4M | -$1.7M | -$781.3K | -$711.9K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $2.2M | $980.3K | -$3.2M | |
| Proceeds From Repayments Of Lines Of Credit | $7.5M | -$2.8M | -$4.9M | $5.3M |
| Payments To Acquire Property Plant And Equipment | $2.2M | $840.4K | $1.1M | $57.8K |
| Net Cash Provided By Used In Investing Activities | -$2.9M | -$1.8M | -$1.1M | -$51.9K |
| Net Cash Provided By Used In Financing Activities | $7.5M | -$2.8M | $7.0M | $3.3M |
| Increase Decrease In Other Noncurrent Assets | $344.7K | -$883.1K | -$860.8K | $2.8M |
| Increase Decrease In Operating Lease Liability | -$2.2M | -$1.3M | -$1.4M | -$1.2M |
| Increase Decrease In Inventories | $4.0M | -$3.4M | -$8.0M | $13.0M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $1.9M | $459.1K | -$1.9M | $2.5M |
| Increase Decrease In Accrued Income Taxes Payable | -$165.9K | $155.8K | -$1.2M | $640.9K |
| Increase Decrease In Accounts Receivable | $4.9M | $1.1M | -$13.5M | $11.1M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$461.1K | $98.6K | -$743.5K | -$182.3K |
| Stock Issued During Period Value Share Based Compensation | $401.2K | $418.0K | $383.6K | |
| Share Based Compensation | $401.2K | $418.0K | $383.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$7.4M | -$8.0M | -$1.2M | -$9.1M | -$814.7K | ||||||
| Proceeds From Repayments Of Lines Of Credit | -$1.3M | $4.5M | -$1.4M | $1.7M | -$54.7K | ||||||
| Payments To Acquire Property Plant And Equipment | $349.9K | $609.0K | $74.2K | $24.4K | $1.7K | ||||||
| Net Cash Provided By Used In Investing Activities | -$450.2K | -$911.4K | -$74.2K | -$24.4K | -$1.7K | ||||||
| Net Cash Provided By Used In Financing Activities | -$1.3M | $4.5M | -$1.4M | $14.0M | -$1.4M | ||||||
| Increase Decrease In Other Noncurrent Assets | -$174.7K | $364.7K | $43.8K | $606.3K | $793.4K | ||||||
| Increase Decrease In Operating Lease Liability | -$417.3K | -$344.4K | -$421.1K | -$311.2K | -$100.6K | ||||||
| Increase Decrease In Inventories | -$1.4M | $1.6M | -$3.4M | $317.3K | -$149.8K | ||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$605.5K | -$612.2K | -$576.7K | -$499.4K | $289.0K | ||||||
| Increase Decrease In Accrued Income Taxes Payable | $17.8K | -$419.2K | $130.5K | -$617.0K | $298.9K | ||||||
| Increase Decrease In Accounts Receivable | -$823.2K | $239.2K | -$1.7M | -$5.9M | $1.3M | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $100.9K | -$40.3K | -$13.9K | -$34.4K | $17.5K | ||||||
| Stock Issued During Period Value Share Based Compensation | $114.1K | $124.6K | $76.3K | $208.5K | $208.5K | $119.6K | $59.3K | $152.8K | $119.7K | ||
| Share Based Compensation | $76.3K | $119.6K | $119.7K | $39.8K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 9.6M | 9.5M | 9.3M | 7.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 9.6M | 9.8M | 9.3M | 7.0M |
| Earnings Per Share Diluted | $-0.13 | $0.07 | $0.39 | $1.13 |
| Earnings Per Share Basic | $-0.13 | $0.08 | $0.39 | $1.13 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 9.5M | 9.5M | 7.0M | |
| Common Stock Shares Outstanding | 9.5M | 9.5M | 7.0M | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Authorized | 40.0M | 40.0M | 200.0M | 40.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 1.9M | 1.9M | 9.6M | 1.9M | 1.9M | 9.5M | 9.5M | 9.5M | 9.5M | 9.5M | 9.2M | 8.8M | 7.0M | 7.0M | 7.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 1.9M | 1.9M | 9.6M | 1.9M | 1.9M | 9.5M | 9.8M | 9.7M | 9.5M | 9.5M | 11.7M | 10.9M | 7.0M | 7.0M | 7.0M | |
| Earnings Per Share Diluted | $-0.86 | $-0.64 | $-0.07 | $-0.29 | $0.08 | $-0.04 | $0.04 | $0.01 | $-0.03 | $0.13 | $0.10 | $0.05 | $0.20 | $0.36 | $0.42 | |
| Earnings Per Share Basic | $-0.86 | $-0.64 | $-0.07 | $-0.29 | $0.09 | $-0.04 | $0.04 | $0.01 | $-0.03 | $0.13 | $0.13 | $0.06 | $0.20 | $0.36 | $0.42 | |
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 10.0M | 2.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Issued | 1.9M | 1.9M | 9.6M | 1.9M | 9.6M | 9.6M | 9.5M | 9.5M | 9.5M | 9.5M | 9.5M | 9.5M | 9.5M | |||
| Common Stock Shares Outstanding | 1.9M | 1.9M | 9.6M | 1.9M | 9.6M | 9.6M | 9.5M | 9.5M | 9.5M | 9.5M | 9.5M | 9.5M | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Provision For Doubtful Accounts | $78.6K | $261.4K | $30.8K | |
| Investment Income Net | $9.8K | $10.5K | ||
| Short Term Borrowings | $7.0M | $9.8M | $14.7M | |
| Interest Paid Net | $1.2M | $749.6K | $600.0K | $406.9K |
| Foreign Currency Transaction Gain Loss Before Tax | $659.5K | -$185.3K | -$7.4K | -$234.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Provision For Doubtful Accounts | $1.9K | $18.4K | $56.9K | $67.6K | $476.00 | ||||||||||
| Investment Income Net | $661.00 | $1.7K | $441.00 | $584.00 | $4.1K | $554.00 | $1.1K | $4.0K | $1.4K | $306.00 | $102.00 | $31.00 | -$68.00 | ||
| Short Term Borrowings | $14.1M | $12.6M | $13.2M | $14.5M | $12.5M | $9.7M | $11.4M | $8.0M | $7.9M | $8.4M | $13.0M | $14.7M | $16.3M | ||
| Interest Paid Net | $302.8K | $214.0K | $250.3K | $131.0K | $79.9K | ||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | $13.8K | -$18.1K | -$33.9K | $20.5K | $17.9K |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.